Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Among authors: seifert h. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiß V, Jung N, Rieg S, Kern WV, Seifert H; SABATO trial group (with linked authorship to the individuals in the Acknowledgements section). Kaasch AJ, et al. Among authors: seifert h. Trials. 2015 Oct 9;16:450. doi: 10.1186/s13063-015-0973-x. Trials. 2015. PMID: 26452342 Free PMC article. Clinical Trial.
Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016-2020.
Jazmati N, Mischnik A, Kern WV, Behnke M, Chakraborty T, Dinkelacker A, Eisenbeis S, Falgenhauer J, Gastmeier P, Häcker G, Imirzalioglu C, Käding N, Kramme E, Peter S, Piepenbrock E, Rupp J, Schneider C, Schwab F, Seifert H, Tacconelli E, Trauth J, Biehl L, Walker SV, Rohde AM; DZIF R-NET Study Group. Jazmati N, et al. Among authors: seifert h. J Hosp Infect. 2024 Sep;151:161-172. doi: 10.1016/j.jhin.2024.06.007. Epub 2024 Jul 3. J Hosp Infect. 2024. PMID: 38969208 Free article.
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.
Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Jaschinski U, Meier-Hellmann A, Weyland A, Gründling M, Moerer O, Riessen R, Seibel A, Ragaller M, Büchler MW, John S, Bach F, Spies C, Reill L, Fritz H, Kiehntopf M, Kuhnt E, Bogatsch H, Engel C, Loeffler M, Kollef MH, Reinhart K, Welte T; German Study Group Competence Network Sepsis (SepNet). Brunkhorst FM, et al. JAMA. 2012 Jun 13;307(22):2390-9. doi: 10.1001/jama.2012.5833. JAMA. 2012. PMID: 22692171 Clinical Trial.
Torsional Twist of the SARS-CoV and SARS-CoV-2 SUD-N and SUD-M domains.
Rosas-Lemus M, Minasov G, Brunzelle JS, Taha TY, Lemak S, Yin S, Shuvalova L, Rosecrans J, Khanna K, Seifert HS, Savchenko A, Stogios PJ, Ott M, Satchell KJF. Rosas-Lemus M, et al. Among authors: seifert hs. bioRxiv [Preprint]. 2024 Aug 14:2024.08.13.607777. doi: 10.1101/2024.08.13.607777. bioRxiv. 2024. PMID: 39185168 Free PMC article. Preprint.
Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software.
Engesser C, Henkel M, Alargkof V, Fassbind S, Studer J, Engesser J, Walter M, Elyan A, Dugas S, Trotsenko P, Sutter S, Eckert C, Hofmann S, Stalder A, Seifert H, Cornford P, Stieltjes B, Wetterauer C. Engesser C, et al. Among authors: seifert h. Sci Rep. 2024 Aug 18;14(1):19113. doi: 10.1038/s41598-024-70292-y. Sci Rep. 2024. PMID: 39155288 Free PMC article.
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 years.
Kluberg SA, Simon AL, Alam SM, Peters A, Horgan C, Li D, Moyneur E, Messenger-Jones E, Platt R, McMahill-Walraven CN, Djibo DA, Daniels K, Jamal-Allial A, Pernar CH, Ziyadeh NJ, Ma Q, Selvan M, Spence O, Oraichi D, Seifert H, Franck V, Gamble S, Yun H. Kluberg SA, et al. Among authors: seifert h. Semin Arthritis Rheum. 2024 Oct;68:152518. doi: 10.1016/j.semarthrit.2024.152518. Epub 2024 Jul 14. Semin Arthritis Rheum. 2024. PMID: 39079205 Free article.
In vitro activity of ozenoxacin against Staphylococcus aureus and Streptococcus pyogenes clinical isolates recovered in a worldwide multicentre study (2020-2022).
García-Castillo M, Hernández-García M, Correa A, Coppi M, Griener T, Fritsche T, Pitart C, Sampaio J, Seifert H, Wake K, Wootton M, Vila J, Cantón R. García-Castillo M, et al. Among authors: seifert h. JAC Antimicrob Resist. 2024 Jun 13;6(3):dlae088. doi: 10.1093/jacamr/dlae088. eCollection 2024 Jun. JAC Antimicrob Resist. 2024. PMID: 38872714 Free PMC article.
981 results